Concepedia

Karim Abou-Nassar

KA

Statistics

Publications

9

Citations

1.1K

H-Index

9

Active since

2007

Affiliations

Dana-Farber Cancer Institute(Current)

Ottawa Hospital

University of Ottawa

Cégep de l'Outaouais

Centre intégré de santé et des services sociaux de l’Outaouais

Karim Abou-Nassar is an author at Dana-Farber Cancer Institute specializing in medicine, oncology, and pharmacotherapy.

Publications per year

2007–2018

9

Publications

9

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer

Marc Carrier, Karim Abou-Nassar, Ranjeeta Mallick et al. · New England Journal of Medicine · 2018 · 847 citations · Full text

, , +17

The Impact of Geographic Proximity to Transplant Center on Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation

Karim Abou-Nassar, Haesook T. Kim, Jeff Blossom et al. · Biology of Blood and Marrow Transplantation · 2011 · 58 citations · Full text

, , +13

The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia

Karim Abou-Nassar, Michael J. Kovacs, Susan Kahn et al. · Thrombosis and Haemostasis · 2007 · 34 citations

, , +17

Novel agents for the treatment of chronic lymphocytic leukemia.

Karim Abou-Nassar, Jennifer R. Brown · PubMed · 2010 · 31 citations

, , +16

Dynamo: A Phase 2 Study Demonstrating the Clinical Activity of Duvelisib in Patients with Relapsed Refractory Indolent Non-Hodgkin Lymphoma

Ian W. Flinn, Carole B. Miller, Kirit M. Ardeshna et al. · Blood · 2016 · 25 citations

, , +9

1–5 of 9